grc 17356

Small moleculeexperimental

Clinical trial activity

1 trials · 14 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0

Earliest trial started Nov 1, 2012 (NCT01726413)

Timeline

2010s

  1. Jan 1, 2012

    Earliest Phase 2 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • grc 17356

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT01726413Phase 2Nov 1, 2012Arthur Asirvathma Hospital, Azad University, Bangalore Clinisearch, DADO Medical s.r.o, Getwell Hospital and Research Centre, Glenmark Pharmaceuticals, ICON, Jehangir Clinical Development Centre Pvt. Ltd., Jnana Sanjeevani Medical Centre, K.L.E.S Dr. Prabhakar Kore Hospital & Medical research Centre, Kovai Medical Centre and Hospital, Coimbatore, MV Hospital and Research Center, NeuroHelp, TOTALL Diabetes Hormone Institute
Showing 1 of 1 trials
Page 1 / 1

Organizations

Research & Development (14)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Arthur Asirvathma HospitalAcademic/Hospital1012012
Azad UniversityAcademic/Hospital1012012
Bangalore ClinisearchAcademic/Hospital1012012
DADO Medical s.r.oAcademic/Hospital1012012
Getwell Hospital and Research CentreAcademic/Hospital1012012
Glenmark PharmaceuticalsFor profit1112012
ICONFor profit1012012
Jehangir Clinical Development Centre Pvt. Ltd.For profit1012012
Jnana Sanjeevani Medical CentreAcademic/Hospital1012012
K.L.E.S Dr. Prabhakar Kore Hospital & Medical research CentreAcademic/Hospital1012012
Kovai Medical Centre and Hospital, CoimbatoreAcademic/Hospital1012012
MV Hospital and Research CenterAcademic/Hospital1012012
NeuroHelpFor profit1012012
TOTALL Diabetes Hormone InstituteAcademic/Hospital1012012
14 organizations
Page 1 / 1